Heron Therapeutics, Inc. (HRTX) Deep Dive Video

Name: Heron Therapeutics, Inc. (HRTX) Deep Dive Video | Flash
Uploaded: 2026-06-28T20:05:10.253Z
Description: Heron Therapeutics is a deeply distressed but potentially asymmetric biotech turnaround, where ZYNRELEF’s reimbursement-driven acute-care ramp must outrun CINVANTI generic erosion, debt pressure, and Nasdaq delisting risk.

Heron Therapeutics, Inc. (HRTX) video thumbnail

Summary

Heron Therapeutics is a deeply distressed but potentially asymmetric biotech turnaround, where ZYNRELEF’s reimbursement-driven acute-care ramp must outrun CINVANTI generic erosion, debt pressure, and Nasdaq delisting risk.

View HRTX stock page · Read the HRTX research report

Loading the video player…

Loading Flash…